# FDA Inspection 824137 - Octapharma Plasma, Inc. - March 21, 2013

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/cadbea1a-d4eb-4049-a352-963285e809be
Source feed: FDA_Inspections

> FDA Inspection 824137 for Octapharma Plasma, Inc. on March 21, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 824137
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2013-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1230736 - 2024-03-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e0186f19-b68e-4834-b64b-56c989c01da6)
- [FDA Inspection 1053924 - 2018-05-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/65b7ba4d-aa0b-45ba-bcd1-a5614d8f6a3a)
- [FDA Inspection 947463 - 2015-08-10](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/52d76d85-6aa1-4db6-8818-5bcdddc91758)
- [FDA Inspection 824403 - 2013-03-20](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0501bd40-89c3-45c3-8c98-873abef11635)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/ff648f25-d2e8-49f9-a56a-e67f2f9030d7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d